---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-123970"
form_type: "8-K"
ticker: "LYEL"
cik: "0001806952"
company_name: "Lyell Immunopharma, Inc."
filed_at: "2025-05-21T23:59:59+00:00"
generated_at: "2026-05-20T22:41:52.100070+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Lyell shareholders elect Friedman, approve auditor, say-on-pay, and reverse split authorization up to 1-for-25

## Summary
- Class I director Catherine Friedman elected with 156.3M votes for (96.3% of votes cast).
- Ratification of Ernst & Young as auditor approved: 212.0M for, 0.3M against.
- Advisory say-on-pay passed with 160.7M votes for (99.0% of votes cast).
- Reverse stock split authorization approved: 199.9M for (94.2% of votes cast), ratio range 1:10 to 1:25 at Board's discretion.

## SEC filing metadata
- accession: 0001193125-25-123970
- form_type: 8-K
- ticker: LYEL
- cik: 0001806952
- company_name: Lyell Immunopharma, Inc.
- filed_at: 2025-05-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1806952/000119312525123970/0001193125-25-123970-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1806952/000119312525123970/d920680d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-123970
- JSON: https://secwatch.observer/filing/0001193125-25-123970.json
- Plain text: https://secwatch.observer/filing/0001193125-25-123970.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.